). In contrast, Bertone-Johnson and colleagues (28) reported that high plasma 25(OH)D levels modestly reduced risk of breast cancer in the NHS cohort (RR for quintile 5 vs. quintile 1 Z 0.73; 95% CI Z 0.49–1.07; p for trend Z 0.06). The RR for 1,25(OH)2D levels was